Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis

OBJECTIVE: Despite multiple drugs available, a large proportion of patients with generalized anxiety disorder (GAD) do not show adequate response and remission. Thus, additional novel pharmacological agents are needed to increase treatment option for GAD. We aimed to investigate efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sheng-Min, Woo, Young Sup, Kim, Nak-Young, Na, Hae-Ran, Lim, Hyun Kook, Bahk, Won-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383014/
https://www.ncbi.nlm.nih.gov/pubmed/32702221
http://dx.doi.org/10.9758/cpn.2020.18.3.423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383014/
https://www.ncbi.nlm.nih.gov/pubmed/32702221
http://dx.doi.org/10.9758/cpn.2020.18.3.423

Ejemplares similares